Tag: nerandomilast

UAE Strengthens access to innovative care with New Fibrosis Drug Approval

The Emirates Drug Establishment has approved Jascaydยฎ (nerandomilast) for the treatment of…

ME Desk

Boehringer Ingelheim to submit nerandomilast for IPF treatment approval

Ingelheim, Germany- September 2024- Boehringer Ingelheim announced that the FIBRONEERโ„ข-IPF trial met…

ME Desk